Pralatrexate mediates effective killing of gemcitabine-resistant pancreatic cancer: role of mTOR/4E-BP1 signal pathway
出版年份 2022 全文链接
标题
Pralatrexate mediates effective killing of gemcitabine-resistant pancreatic cancer: role of mTOR/4E-BP1 signal pathway
作者
关键词
-
出版物
Heliyon
Volume 8, Issue 12, Pages e12064
出版商
Elsevier BV
发表日期
2022-12-06
DOI
10.1016/j.heliyon.2022.e12064
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pancreatic Cancer
- (2021) Wungki Park et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer
- (2020) Wenbin Li et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Pralatrexate injection for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma
- (2020) Zhao Jennifer C et al. Expert Review of Hematology
- Role and mechanism of autophagy‐regulating factors in tumorigenesis and drug resistance
- (2020) Rana Muhammad Usman et al. Asia-Pacific Journal of Clinical Oncology
- PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
- (2020) Maddison Rose et al. Frontiers in Cell and Developmental Biology
- Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
- (2020) Volker Kunzmann et al. Lancet Gastroenterology & Hepatology
- Chemoresistance in Pancreatic Cancer
- (2019) Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Targeting autophagy-related protein kinases for potential therapeutic purpose
- (2019) Honggang Xiang et al. Acta Pharmaceutica Sinica B
- Neoadjuvant and adjuvant chemotherapy in pancreatic cancer
- (2018) Ulla Klaiber et al. LANGENBECKS ARCHIVES OF SURGERY
- Mechanistic Target of Rapamycin Is a Novel Molecular Mechanism Linking Folate Availability and Cell Function
- (2017) Elena Silva et al. JOURNAL OF NUTRITION
- Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
- (2017) John P Neoptolemos et al. LANCET
- Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors
- (2017) İlhan Elmaci et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Endothelial functions of platelet/endothelial cell adhesion molecule-1 (CD31)
- (2016) Panida Lertkiatmongkol et al. CURRENT OPINION IN HEMATOLOGY
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Akt/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells
- (2012) Shingo Kagawa et al. JOURNAL OF SURGICAL RESEARCH
- Inhibitory Effect of mTOR Activator MHY1485 on Autophagy: Suppression of Lysosomal Fusion
- (2012) Yeon Ja Choi et al. PLoS One
- Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
- (2012) Chen Sun WORLD JOURNAL OF GASTROENTEROLOGY
- Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study
- (2011) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetic drug–drug interactions with methotrexate in oncology
- (2011) Dominique Levêque et al. Expert Review of Clinical Pharmacology
- Pralatrexate Is Synergistic with the Proteasome Inhibitor Bortezomib in In vitro and In vivo Models of T-Cell Lymphoid Malignancies
- (2010) E. Marchi et al. CLINICAL CANCER RESEARCH
- Phase II-I-II Study of Two Different Doses and Schedules of Pralatrexate, a High-Affinity Substrate for the Reduced Folate Carrier, in Patients With Relapsed or Refractory Lymphoma Reveals Marked Activity in T-Cell Malignancies
- (2009) Owen A. O'Connor et al. JOURNAL OF CLINICAL ONCOLOGY
- Palliative treatment of pancreatic cancer
- (2008) Götz VON WICHERT et al. Journal of Digestive Diseases
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started